Methylene Blue for the Treatment of Oral Mucositis Associated to Cancer
Treatment in Pediatrics
- Carlos J. Roldan,
- Tolulope Oso
Carlos J. Roldan
The University of Texas MD Anderson Cancer Center
Corresponding Author:croldan@mdanderson.org
Author ProfileTolulope Oso
The University of Texas MD Anderson Cancer Center
Author ProfileAbstract
Here, we report the use of a methylene blue oral rinse for the treatment
of oral mucositis--associated pain. A child receiving chemotherapy for
acute lymphoblastic leukemia had progressive decline in clinical
condition from uncontrolled oral pain associated with mucositis.
Conventional therapy was shown to be ineffective and eventually
discontinued. The patient received a methylene oral rinse treatment,
which provided good pain control and allowed him to recover successfully
completing his chemotherapy. The use of the methylene blue oral rinse
can be a safe, inexpensive, and effective treatment for
mucositis-related oral pain in the pediatric cancer patient population.